Back
Century Therapeutics
IPOIPSC.NASDAQPast

Century Therapeutics

developer of allogeneic living drugs created to offer treatment for cancer

Company website ↗
Foundation year: 2018
Profitability
+34%
IPO date
17/06/2021

About

Total Funding 

$560M


Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer. The company's genetically-engineered, iPSC-derived immune effector cell products are designed to specifically target hematologic and solid cancers by harnessing the power of adult stem cells, providing patients with an unparalleled opportunity to advance the course of cancer care.


Number of employees

100-150


Headquarters

Philadelphia, Pennsylvania, United States